Cero Therapeutics Holdings, Inc. to present a poster on the lead program, CER-1236, at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting.

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.